Aly-Khan A Lalani (Aly-Khan Lalani)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Combination Therapy

Systematic Review

Small Cell Lung Cancer

Renal Cell Carcinoma

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Human vaccines & immunotherapeutics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, Lori A Wood, Georg Arnold Bjarnason, Bimal Bhindi, Daniel Yick Chin Heng, Vincent Castonguay, Frédéric Pouliot, Christian K Kollmannsberger, Dominick Bosse, Naveen S Basappa, Antonio Finelli, Nazanin Fallah-Rad, Rodney H Breau, Aly-Khan A Lalani, Simon Tanguay, Jeffrey Graham, Ramy R Saleh
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. Current oncology (Toronto, Ont.) 31 (8) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, Lori A Wood, Georg Arnold Bjarnason, Bimal Bhindi, Daniel Yick Chin Heng, Vincent Castonguay, Frédéric Pouliot, Christian K Kollmannsberger, Dominick Bosse, Naveen S Basappa, Antonio Finelli, Nazanin Fallah-Rad, Rodney H Breau, Aly-Khan A Lalani, Simon Tanguay, Jeffrey Graham, Ramy R Saleh
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. Current oncology (Toronto, Ont.) 31 (8) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, Lori A Wood, Georg Arnold Bjarnason, Bimal Bhindi, Daniel Yick Chin Heng, Vincent Castonguay, Frédéric Pouliot, Christian K Kollmannsberger, Dominick Bosse, Naveen S Basappa, Antonio Finelli, Nazanin Fallah-Rad, Rodney H Breau, Aly-Khan A Lalani, Simon Tanguay, Jeffrey Graham, Ramy R Saleh
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. Current oncology (Toronto, Ont.) 31 (8) (2024)
Pooya Dibajnia, Luisa M Cardenas, Aly-Khan A Lalani
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma. Human vaccines & immunotherapeutics 19 (1) (2023)
Luisa M Cardenas, Sunita Ghosh, Antonio Finelli, Lori Wood, Christian K Kollmannsberger, Naveen S Basappa, Jeffrey Graham, Daniel Heng, Georg Bjarnason, Denis Soulieres, Dominick Bosse, Vincent Castonguay, Ramy Saleh, Simon Tanguay, Bimal Bhindi, Rodney H Breau, Frédéric Pouliot, Aly-Khan A Lalani
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System. JCO global oncology 9 (2023)
Pooya Dibajnia, Luisa M Cardenas, Aly-Khan A Lalani
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma. Human vaccines & immunotherapeutics 19 (1) (2023)
Pooya Dibajnia, Luisa M Cardenas, Aly-Khan A Lalani
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma. Human vaccines & immunotherapeutics 19 (1) (2023)
Pooya Dibajnia, Luisa M Cardenas, Aly-Khan A Lalani
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma. Human vaccines & immunotherapeutics (2023)
Pooya Dibajnia, Luisa M Cardenas, Aly-Khan A Lalani
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma. Human vaccines & immunotherapeutics 19 (1) (2023)
Pooya Dibajnia, Luisa M Cardenas, Aly-Khan A Lalani
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma. Human vaccines & immunotherapeutics 19 (1) (2023)
Aly-Khan A Lalani, Daniel Y C Heng, Naveen S Basappa, Lori Wood, Nayyer Iqbal, Deanna McLeod, Denis Soulières, Christian Kollmannsberger
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review. Therapeutic advances in medical oncology 14 (2022)
Luisa M Cardenas, Jasna E Deluce, Shahrukh Khan, Omar Gulam, Saman Maleki Vareki, Ricardo Fernandes, Aly-Khan A Lalani
Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma. Current oncology (Toronto, Ont.) 29 (8) (2022)
Jasna E Deluce, Luisa Cardenas, Aly-Khan A Lalani, Saman Maleki Vareki, Ricardo Fernandes
Emerging Biomarker-Guided Therapies in Prostate Cancer. Current oncology (Toronto, Ont.) 29 (7) (2022)
Mehmet Asim Bilen, Brian I Rini, Martin H Voss, James Larkin, John B A G Haanen, Laurence Albiges, Lance C Pagliaro, Eric G Voog, Elaine T Lam, Nikolay Kislov, Bradley Alexander McGregor, Aly-Khan A Lalani, Bo Huang, Alessandra di Pietro, Stan Krulewicz, Paul B Robbins, Toni K Choueiri
Association of Neutrophil-to-Lymphocyte Ratio With Efficacy of First-Line Avelumab Plus Axitinib vs Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Suraya Bondy, Camilla Tajzler, Sebastien J Hotte, Anil Kapoor, Kevin Zbuk, Aly-Khan A Lalani
Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report. Current oncology (Toronto, Ont.) 28 (1) (2020)
Haoxin Li, Kevin Bullock, Carino Gurjao, David Braun, Sachet A Shukla, Dominick Bosse, Aly-Khan A Lalani, Shuba Gopal, Chelsea Jin, Christine Horak, Megan Wind-Rotolo, Sabina Signoretti, David F McDermott, Gordon J Freeman, Eliezer Van Allen, Stuart L Schreiber, F Stephen Hodi, William R Sellers, Levi A Garraway, Andrew T Chan, Toni K Choueiri, Marios Giannakis
Metabolomic adaptations and correlates of survival to immune checkpoint blockade. Nature communications 10 (1) (2019)
Joaquim Bellmunt, Aly-Khan A Lalani, Sussana Jacobus, Stephanie A Wankowicz, Laura Polacek, David Y Takeda, Lauren C Harshman, Nikhil Wagle, Irene Moreno, Kevin Lundgren, Dominick Bossé, Eliezer M Van Allen, Toni K Choueiri, Jonathan E Rosenberg
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British journal of cancer 119 (6) (2018)
Aly-Khan A Lalani, Guru P Sonpavde
Systemic treatments for metastatic urothelial carcinoma. Expert opinion on pharmacotherapy 20 (2) (2018)
Fengju Chen, Yiqun Zhang, Dominick Bossé, Aly-Khan A Lalani, A Ari Hakimi, James J Hsieh, Toni K Choueiri, Don L Gibbons, Michael Ittmann, Chad J Creighton
Pan-urologic cancer genomic subtypes that transcend tissue of origin. Nature communications 8 (1) (2017)